Get the Stockscreener App
24.78
2.79%
-0.71
After Hours:
25.29
0.51
+2.06%
Doximity Inc stock is traded at $24.78, with a volume of 2.84M.
It is down -2.79% in the last 24 hours and down -9.03% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$25.49
Open:
$25.37
24h Volume:
2.84M
Relative Volume:
0.80
Market Cap:
$4.58B
Revenue:
$637.78M
Net Income/Loss:
$239.40M
P/E Ratio:
20.81
EPS:
1.1909
Net Cash Flow:
$307.21M
1W Performance:
-8.12%
1M Performance:
-9.03%
6M Performance:
-64.09%
1Y Performance:
-59.01%
1-Day Range:
$24.09
$25.71
1-Week Range:
$24.09
$27.09
52-Week Range:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, MMED
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.78 | 4.71B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
189.69 | 32.15B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.90 | 9.35B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.34 | 8.11B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.50 | 6.84B | 1.15B | 96.70M | -161.99M | 1.09 |
|
MMED
Minimed Group Inc
|
18.33 | 5.05B | 0 | 0 | 0 | 0.00 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (NASDAQ:DOCS) Receives "Outperform" Rating from Royal Bank Of Canada - MarketBeat
What Analysts Are Saying About Doximity Stock - Benzinga
Rhenman & Partners Asset Management AB Increases Stake in Doximity, Inc. - National Today
Rhenman & Partners Asset Management AB Increases Position in Doximity, Inc. $DOCS - MarketBeat
Blair William & Co. IL Acquires 345,390 Shares of Doximity, Inc. $DOCS - MarketBeat
What Wall Street predicts for Doximity Inc. stock price2026 Key Lessons & Verified Chart Pattern Signals - Naître et grandir
(DOCS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Victory Capital Management Inc. Acquires 921,533 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Director Sells $52,000.00 in Stock - MarketBeat
Assessing Doximity (DOCS) Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform - simplywall.st
Is Doximity Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Breakouts Watch: Is Doximity Inc stock a hidden gemWall Street Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Hims and Hers Expands Its Technology Driven Consumer Health Platform - The Globe and Mail
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Doximity Analysts Set $44.50 Average Price Target - National Today
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance
DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan
Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - Sahm
Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? - Yahoo Finance
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Intech Investment Management Trims Doximity Holdings - National Today
Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews
Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm
Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo
Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity’s $31 Million Investor Settlement Clears Initial Hurdle - Bloomberg Law News
Doximity Stock Hits Day Low of $23.58 Amid Price Pressure - Markets Mojo
Doximity, Inc. Stock Plummets to New 52-Week Low of $23.58 - Markets Mojo
Doximity Stock Analysts Adjust Ratings and Targets - National Today
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Doximity (DOCS) Price Target Decreased by 31.04% to 44.25 - Nasdaq
(DOCS) Risk Channels and Responsive Allocation - Stock Traders Daily
Doximity stock hits 52-week low at $23.65 amid challenging year - Investing.com Australia
Doximity (NASDAQ:DOCS) Sets New 12-Month Low on Analyst Downgrade - MarketBeat
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight. - The Motley Fool
Piper Sandler raises Doximity stock price target on AI tools By Investing.com - Investing.com Australia
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co. - MarketBeat
Piper Sandler raises Doximity stock price target on AI tools - Investing.com
Piper Sandler Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Piper Sandler Raises Price Target for Doximity (DOCS) to $42 | D - GuruFocus
Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Why Doximity Stock Plummeted Today - AOL.com
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.13%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):